Clinical Trial Update: Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel and cisplatin with radiation, with or without cetuximab, in hypopharyngeal and laryngeal squamous cell carcinomas; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: ClinAssess | Conditions: Squamous Cell Carcinoma of the Hypopharynx, Larynx Carcinoma | Phase 2 | Status: COMPLETED